These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6446722)

  • 1. Serotonergic involvement in neuroendocrine function.
    Schettini G; Quattrone A; Di Renzo G; Preziosi P
    Pharmacol Res Commun; 1980 Mar; 12(3):249-54. PubMed ID: 6446722
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat.
    Iovino M; Steardo L
    Eur J Pharmacol; 1985 Jul; 113(1):99-103. PubMed ID: 2931284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides.
    Spampinato S; Locatelli V; Cocchi D; Vicentini L; Bajusz S; Ferri S; Müller EE
    Endocrinology; 1979 Jul; 105(1):163-70. PubMed ID: 221198
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of selective lesioning of serotonin-containing neurons on the TSH-inhibiting action of d-fenfluramine in male rats.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1979 Feb; 24(6):489-94. PubMed ID: 431332
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible involvement of the septo-hippocampal cholinergic and raphe-hippocampal serotonergic activations in the penile erection induced by fenfluramine in rats.
    Maeda N; Matsuoka N; Yamaguchi I
    Brain Res; 1994 Aug; 652(2):181-9. PubMed ID: 7953728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus.
    Wirtshafter D; Klitenick MA; Asin KE
    Pharmacol Biochem Behav; 1987 May; 27(1):45-52. PubMed ID: 2441421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
    Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
    Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO; Menadue M; Jervois P
    Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of selective degeneration of brain serotonin-containing neurons on plasma corticosterone levels: studies with d-fenfluramine.
    Schettini G; Quattrone A; Gianfranco DR; Preziosi P
    Pharmacol Res Commun; 1979 Jun; 11(6):545-53. PubMed ID: 504327
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain.
    Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S
    Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652
    [No Abstract]   [Full Text] [Related]  

  • 16. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: pharmacological evidence.
    Wang RY; Aghajanian GK
    Neuropharmacology; 1978 Oct; 17(10):819-25. PubMed ID: 154620
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus.
    Van de Kar LD; Bethea CL
    Neuroendocrinology; 1982 Oct; 35(4):225-30. PubMed ID: 7145018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
    Broekkamp CL; Garrigou D; LLoyd KG
    Pharmacol Biochem Behav; 1980 Nov; 13(5):643-6. PubMed ID: 6969405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.